University of Surrey scientists unveil new approach to treat brain tumours
The University of Surrey scientists showed in a study that HTL-001 peptide could hinder function of Hox genes that causes GBM growth.
Source: pharmaceutical-technology.com
Stay updated with breaking news from Compaction Simulation. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The University of Surrey scientists showed in a study that HTL-001 peptide could hinder function of Hox genes that causes GBM growth.
While much progress has been made in some rare neurological diseases, others are only beginning to see interest from developers.